NCT04236180

Brief Summary

This study evaluates the effectiveness of an existing Specialised Paediatric Palliative Care programme and reports on its potential to improve patient-, family-, health professionals-, and healthcare-related outcomes. Data will be compared between an intervention and a comparison group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 15, 2019

Completed
8 months until next milestone

Study Start

First participant enrolled

November 5, 2019

Completed
3 months until next milestone

First Posted

Study publicly available on registry

January 22, 2020

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2023

Completed
Last Updated

December 15, 2023

Status Verified

December 1, 2023

Enrollment Period

3.6 years

First QC Date

March 15, 2019

Last Update Submit

December 14, 2023

Conditions

Keywords

PaediatricsPalliative Care

Outcome Measures

Primary Outcomes (1)

  • Change in Caregiver QOL - QOLLTI-F Questionnaire

    Longitudinal assessment of self-reported caregiver (parental) Quality of Life (QOL) using the QOLLTI-F (Quality of Life in Life Threatening Illness - Family Carer Version) questionnaire.

    Up to day 330 after study entry

Secondary Outcomes (7)

  • Change in Child's QOL - DISABKIDS Chronic Generic Measure (DCGM-37) Questionnaire

    Up to day 330 after study entry

  • Change in child's symptoms - Memorial Symptom Assessment Scale (MSAS) Questionnaire

    Up to day 330 after study entry

  • Change in Siblings QOL - KIDSSCREEN-27 Questionnaire

    Up to day 630 after study entry

  • Professional's QOL (ProQOL) Questionnaire

    Cross-sectional at the end of study year 1

  • Professional's QOL (ProQOL) Questionnaire

    Cross-sectional at the end of study year 2

  • +2 more secondary outcomes

Other Outcomes (11)

  • Number of hospital admissions as assessed longitudinally via chart review

    Up to day 330 after study entry

  • Number of resuscitations

    Up to day 330 after study entry

  • Number of invasive procedures

    Up to day 330 after study entry

  • +8 more other outcomes

Study Arms (2)

Intervention Group

ACTIVE COMPARATOR

Patients enrolled in the Specialised Paediatric Palliative Care (SPPC) programme at the University Children's Hospital Zurich.

Other: Specialised Paediatric Palliative Care (SPPC)

Comparison Group

NO INTERVENTION

Patients treated at the Children's Hospital Aarau, University Children's Hospital Basel, and the University Hospital Inselspital Bern.

Interventions

All services provided to children/families by a member of the multiprofessional SPPC team in Zurich according to local guidelines will be considered as study intervention. This includes direct consultation of the patient/family, as well as patient-/family-related consultation of the frontline care team. Bereavement support is considered an integrated part of SPPC and after the death of a child, follow-up bereavement support is routinely offered at the individual or group level as appropriate for parents and siblings.

Intervention Group

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Children, aged 0-18 years, suffering from a life-limiting condition of various origins and potentially in need of SPPC (for Zurich, additionally enrolment in the SPPC programme)
  • Parents (mothers and fathers) of included children
  • Siblings, aged \>8 years, of included families
  • All health care professionals involved in the care of included families
  • Proficiency in French or German language
  • Signed Informed Consent after being informed

You may not qualify if:

  • Neonates with medical complications due to prematurity and/or birth complications and treated in a neonatal intensive care unit
  • Children with an estimated life expectancy of \<48 hours

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Cantonal Children's Hospital

Aarau, Switzerland

Location

University Children's Hospital

Basel, Switzerland

Location

Department of Pediatrics, University Hospital Inselspital

Bern, Switzerland

Location

University Children's Hospital Zurich

Zurich, 8032, Switzerland

Location

Related Publications (3)

  • Mitterer S, Zimmermann K, Fink G, Simon M, Gerber AK, Bergstrasser E. Hospitalization- and death-related financial and employment effects in parents of children with life-limiting conditions: a fixed-effects analysis. Eur J Pediatr. 2024 Oct;183(10):4215-4227. doi: 10.1007/s00431-024-05680-7. Epub 2024 Jul 10.

  • Gerber AK, Feuz U, Zimmermann K, Mitterer S, Simon M, von der Weid N, Bergstrasser E. Work-related quality of life in professionals involved in pediatric palliative care: a repeated cross-sectional comparative effectiveness study. Palliat Care Soc Pract. 2024 May 9;18:26323524241247857. doi: 10.1177/26323524241247857. eCollection 2024.

  • Zimmermann K, Simon M, Scheinemann K, Tinner Oehler EM, Widler M, Keller S, Fink G, Mitterer S, Gerber AK, von Felten S, Bergstraesser E. Specialised Paediatric PAlliativE CaRe: Assessing family, healthcare professionals and health system outcomes in a multi-site context of various care settings: SPhAERA study protocol. BMC Palliat Care. 2022 Nov 2;21(1):188. doi: 10.1186/s12904-022-01089-x.

Study Officials

  • Karin Zimmermann, PhD RN

    University Children's Hospital, Zurich

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Interventional multi-centre study with a hybrid design to determine the clinical effectiveness (comparative effectiveness research) of an existing SPPC programme, while gathering information on its delivery and potential implementation in a real-life situation
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 15, 2019

First Posted

January 22, 2020

Study Start

November 5, 2019

Primary Completion

May 31, 2023

Study Completion

May 31, 2023

Last Updated

December 15, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations